Concepedia

Mina Hassan‐Zahraee

MH

Statistics

Publications

22

Citations

1.1K

H-Index

16

Active since

1995

Affiliations

Pfizer (United States)(Current)

University of California San Diego

Harvard University

Nicolaus Copernicus University

Weill Cornell Medicine

Mina Hassan‐Zahraee is an author at Pfizer (United States) specializing in immunology, life sciences, and inflammatory bowel disease.

ORCID

Publications per year

1995–2024

22

Publications

22

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial

Séverine Vermeire, William J. Sandborn, Silvio Danese et al. · The Lancet · 2017 · 197 citations

, , +14

The Delayed Hypersensitivity Response and Host Resistance in Surgical Patients

Nicolas V. Christou, Jonathan L. Meakins, Julius Gordon et al. · Annals of Surgery · 1995 · 139 citations · Full text

, , +12

Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study

William J. Sandborn, Scott D. Lee, Dino Tarabar et al. · Gut · 2017 · 107 citations · Full text

, , +17

Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study

Silvio Danese, Maria Kłopocka, Ellen Scherl et al. · Clinical Gastroenterology and Hepatology · 2021 · 91 citations · Full text

, , +12

Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study

William J. Sandborn, Silvio Danese, Jarosław Leszczyszyn et al. · Clinical Gastroenterology and Hepatology · 2023 · 89 citations

, , +9

1–5 of 22